Welcome to LookChem.com Sign In|Join Free
  • or
L-Alanine, 3-[[4-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)ethyl]benzoyl]amino]-N- [[4-(trimethylstannyl)phenyl]sulfonyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

312263-46-0

Post Buying Request

312263-46-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

312263-46-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 312263-46-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,2,2,6 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 312263-46:
(8*3)+(7*1)+(6*2)+(5*2)+(4*6)+(3*3)+(2*4)+(1*6)=100
100 % 10 = 0
So 312263-46-0 is a valid CAS Registry Number.

312263-46-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-{4-[2-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-ethyl]-benzoylamino}-2(S)-(4-trimethylstannyl-benzenesulfonylamino)-propionic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:312263-46-0 SDS

312263-46-0Relevant academic research and scientific papers

Dibenzoxazepine alpha v integrin receptor antagonist

-

Page/Page column 11-12, (2010/02/05)

The present invention relates to a novel dibenzoxazepine derivative, its synthesis, and its use as an αv integrin receptor antagonist. More particularly, the compound of the present invention is an antagonist of the integrin receptors αvβ3 and αvβ5 and th

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 312263-46-0